← Leaderboards
Shabir A Madhi
Wits Health Consortium (Pty), Ltd
$10,692,376
Attributed
$12,521,648
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$7,720,503 · 2
NIH$4,801,145 · 4
By mechanism
U19$8,780,493 · 3
U01$2,273,299 · 2
R01$1,467,856 · 1
Top collaborators
- Adriana Weinberg8 shared
Most similar at Wits Health Consortium (Pty), Ltd
Same institution · by research overlap
- Glenda E Gray$398,868,516
Others in their field
Top investigators on “Morbidity - Disease Rate”
- Marco Pahor · Wake Forest University Health Sciences$29,421,775
- A Benedict Cosimi · Massachusetts General Hospital$17,236,164
- Judith S. Currier · University Of California Los Angeles$11,229,603
- Andrea Jenay Ruff · Johns Hopkins University$10,896,035
- Lucile L Adams-Campbell · Howard University$10,384,616
- Michael K Ong · University Of California Los Angeles$9,898,332
Research focus
Morbidity - Disease RateImmune ResponseInfantInfectionEnzyme-Linked Immunosorbent AssayChildHiv-1ChildhoodResponseVaccinesImmunogenicityMothersImmuneHospitalizationAntiretroviral TherapyHiv-Exposed Uninfected InfantHiv InfectionsImmune SystemFrequenciesGut MicrobiotaAffectGut MicrobiomeCessation Of LifeEpigenetic Process
Grant awards (18)
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$761,784
R01 · FY2025 · HD
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$17,647
R01 · FY2025 · HD
Developing Interventions for Protecting HIV-Exposed Uninfected Infants against Severe Infections$688,425
R01 · FY2024 · HD
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$455,979
U01 · FY2021 · AI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$456,248
U01 · FY2020 · AI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$449,834
U01 · FY2019 · AI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$409,739
U01 · FY2018 · AI
Tregs, Gut Microbiome and Immune Responses in HIV-Exposed and Unexposed Infants$418,888
U01 · FY2017 · AI
GH17-003, S. Africa: SUPPORTING THE NATIONAL HEALTH LABORATORY SERVICES TO EXPAND PUBLIC HEALTH RESEARCH ON FIELD AND LAB INVESTIGATIONS$82,611
U01 · FY2017 · GH · contact PI
GH11-1199: GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$510,000
U19 · FY2015 · GH · contact PI
GH11-1199: GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$1,116,948
U19 · FY2014 · GH · contact PI
GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$1,175,729
U19 · FY2013 · GH · contact PI
GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$712,449
U19 · FY2012 · GH · contact PI
GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$4,122,766
U19 · FY2011 · GH · contact PI
Responses to Type B Conjugate Vaccines Amongst HIV-1 Infected Children$99,152
U19 · FY2010 · AI · contact PI
Responses to Type B Conjugate Vaccines Amongst HIV-1 Infected Children$302,698
U19 · FY2009 · AI · contact PI
Responses to Type B Conjugate Vaccines Amongst HIV-1 Infected Children$325,914
U19 · FY2008 · AI · contact PI
Responses to Type B Conjugate Vaccines Amongst HIV-1 Infected Children$414,837
U19 · FY2007 · AI · contact PI